Skip to main content
. 2017 Jun 27;108(8):1648–1656. doi: 10.1111/cas.13282

Figure 3.

Figure 3

Locoregional therapy with astatine‐211‐labeled trastuzumab (211At‐tras) in a mouse model of peritoneal metastasis of gastric cancer (PMGC), and tumor monitoring. (a) Treatment schedule. (b) Representative bioluminescence images of tumor growth in the mouse model treated with PBS (control), unlabeled trastuzumab (Tras), 211At (1 MBq), or 211At‐tras (0.1 or 1 MBq). Images were captured on the day before treatment (Day 0) or at 3, 5, or 7 weeks (w) after treatment. The color scale indicates the luminescence intensity per pixel.